BioTech
Traditional randomized trials don’t work for ultra-rare diseases like Barth syndrome
Another ultra-rare therapy will soon be subject to the gaze of an FDA advisory committee, with the fate of more than 200 boys diagnosed with
Emil D. Kakkis
October 9, 2024
